MD Farma Closes Series A Funding and Changes Name to Corganics as the Company Expands Clinical Cannabinoid (CBD) Product Lines Sold Only in Healthcare Facilities
Home » MD Farma Closes Series A Funding and Changes Name to Corganics as the Company Expands Clinical Cannabinoid (CBD) Product Lines Sold Only in Healthcare Facilities
MD Farma Closes Series A Funding and Changes Name to Corganics as the Company Expands Clinical Cannabinoid (CBD) Product Lines Sold Only in Healthcare Facilities2021-11-302021-12-02http://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.pngRedPepper Mergershttp://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.png200px200px
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.